#adherence — RNews

Top 1d 2d 3d 7d 14d 30d

Show 10 20 50

hot top new

Oct 05 Oct 06 Oct 07 Oct 08 Oct 09 Oct 10 Oct 11

#adherence — top 20, last 30d

0

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial. (linkinghub.elsevier.com)

Bwakura-Dangarembizi M … Pett S The Lancet 2026-09-17

#hiv #clinical trial #adolescent #adherence